YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(7)
- Austria(1)
- Belgium(3)
- Canada(49)
- China(12)
- Colombia(1)
- Denmark(1)
- Finland(2)
- France(9)
- Germany(34)
- Greece(2)
- Hong Kong(1)
- Hungary(2)
- India(68)
- Ireland(1)
- Israel(2)
- Italia (6)
- Japan(1)
- Luxembourg(1)
- Malta(1)
- Mauritius(1)
- Mexico(1)
- Peru(1)
- Poland(1)
- Portugal(3)
- Singapore(1)
- Slovenia(1)
- South Korea(3)
- Spain(9)
- Sweden(2)
- Switzerland(20)
- Taiwan(2)
- The Czech Republic(1)
- The Netherlands(3)
- Turkey(1)
- Ukraine(1)
- United Kingdom(46)
- United States(597)
- Vietnam(1)
Contract Service Directory
Fresenius Kabi
Company Headquarters
Borkenberg 14
Oberursel, 61440
Germany
Contract Service Directory
- API Solubilization Technologies
- Aseptic Processing
- Chemical Analysis
- Clinical Trials, Phase III
- Contract Manufacturing
- Custom Manufacturing
- Disposable Device Development & Manufacturing
- Distribution, Commercial
- Documentation Support Services
- Dosage Form Development
- Drug Delivery Systems
- Feasibility Studies
- Filling, Ampule
- Filling, Syringe
- Filling, Vial
- Formulation Development
- Formulation Services
- Lyophilization
- Manufacturing, Aseptic Fill/Finish
- Manufacturing, Clinical Trials Supply
- Manufacturing, Controlled Substances
- Manufacturing, Dose Form, Non-Sterile
- Manufacturing, Dose Form, Sterile
- Manufacturing, High Containment Operations
- Manufacturing, Injectables
- Manufacturing, Liquids
- Manufacturing, Lyophilized Products
- Manufacturing, Other
- Manufacturing, Parenterals, Large Volume
- Manufacturing, Parenterals, Small Volume
- Manufacturing, Solutions & Suspensions
- Manufacturing, Sustained Release
- Manufacturing, Syringes, Pre-filled
- Packaging, Form/Fill/Seal
- Packaging, Injectables
- Packaging, Liquids
- Packaging, Parenterals
- Parenterals Development
- Parenterals, Ampule Filling
- Parenterals, Vial Filling
- Pilot-Scale Filling
- Preformulation
- Process Development/Scale-Up Services
- Process R&D
- Process Validation Studies
- R&D Services
- Scale-Up
- Shipping
- Stability Studies
- Stability, ICH
- Sterile Filling
- Sterility Testing
- Sterilization
- Sustained Release Delivery Systems
- Syringe Filling
Contract Services Directory
Related Content
-
Breaking News | Collaborations & Alliances | Industry News | Supply Chain
Vizient and Fresenius Kabi Expand Partnership
Complete Novaplus contract enhancement for six critical care drugs.11.26.19
-
Breaking News | Facilities | Industry News
Lilly to Invest $400M in Manufacturing Facilities
Company to add approximately 100 jobs in Indianapolis expansion.11.22.19
-
Biologics, Proteins, Vaccines
Regenerative Medicine: Overcoming the supply chain challenges
Accomplishing the goal of widespread use of regenerative medicine doesn’t come without its challenges.Rich Quelch, Global Head of Marketing, Origin 11.20.19
-
Breaking News | Industry News
Vineti, WuXi AppTec Ink Personalized Therapy Management Platform Pact
To combine Vineti's ordering and traceability platform with WuXi's manufacturing facilities to provide end-to-end solution11.05.19
-
-
APIs
Better Drug Manufacturing Strategies: Custom APIs
Today’s biopharma companies are turning to their contractors for long-term collaboration and much higher levels of support.Tom Wilson, VP, Global Contract Manufacturing Leader, Pfizer CentreOne 10.15.19
-
APIs | cGMP Manufacture | Clinical Trial Materials | Custom Sourcing News | Industry News
Nordic Nanovector, Isotope Technologies Enter Supply Pact
Extend global supply agreement for n.c.a. Lutetium-177 (EndolucinBeta)10.07.19
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
Continued and Consistent Investment in Manufacturing Facilities
As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challengeRyan Carpentier, Executive Director of Business Development, Cryoport 09.23.19
-
-
Cytotoxics and High Potency Manufacturing
API to ADC: A Journey Through High Potency
This class of compounds represents a major advance in oncology research and treatment application.Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19
-
-
-
Collaborations & Alliances | Drug Development
Gilead and Nurix to Collaborate on Novel Therapies
Consisting of targeted protein degradation drugs for patients with cancer and other challenging diseases06.20.19
